Back to Gene
MKRN3 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

MKRN3 gene

The MKRN3 gene provides instructions for making a protein that plays a critical role in regulating the timing of puberty.

Normal Function

The MKRN3 gene provides instructions for making a protein called makorin ring finger protein 3 (MKRN3). This protein plays a role in directing the onset of puberty, the process of sexual development that normally occurs in adolescence. Puberty begins when a gland in the brain called the hypothalamus is stimulated to release bursts of a hormone called gonadotropin releasing hormone (GnRH), which triggers the release of other hormones that direct sexual development. Research suggests that the MKRN3 protein inhibits the release of GnRH from the hypothalamus, effectively delaying the onset of puberty.

While the exact function of the MKRN3 protein is unknown, its structure suggests it plays a role in the ubiquitin-proteasome system, the cell machinery that breaks down unwanted proteins. MKRN3 is thought to help attach a molecule called ubiquitin to unwanted proteins, signaling the cell to break them down. Researchers speculate that MKRN3 adds ubiquitin to proteins that would otherwise stimulate GnRH release, ensuring that puberty does not begin until the appropriate time.

The activity of the MKRN3 gene is subject to genomic imprinting, a phenomenon where gene activation depends on which parent the gene was inherited from. In this case, only the copy inherited from the father is active; the copy inherited from the mother is inactive.

Health Conditions Related to Genetic Changes

Central precocious puberty

More than 20 MKRN3 gene mutations have been identified as causes of central precocious puberty. Individuals with this condition exhibit signs of puberty earlier than normal—before age 8 in girls and before age 9 in boys. These signs include:

  • Development of breasts and the start of a menstrual period in girls
  • Enlargement of the testes and penis in boys
  • Development of pubic hair and a growth spurt in both girls and boys

Mutations in the MKRN3 gene are thought to lead to the production of a nonfunctional protein. Because the copy of the gene inherited from the mother is naturally inactive, affected individuals produce no functional MKRN3 protein. Without this protein to inhibit GnRH release, the hypothalamus releases hormone bursts prematurely, triggering early puberty. Because only the paternal copy of the gene is active, this condition can only be inherited from a person's father.

Other Names for This Gene

  • CPPB2
  • D15S9
  • MGC88288
  • probable E3 ubiquitin-protein ligase makorin-3
  • RING finger protein 63
  • RNF63
  • ZFP127
  • zinc finger protein 127
  • ZNF127

Frequently Asked Questions

Yes. Loss‑of‑function mutations in the paternally inherited MKRN3 gene are one of the most common genetic causes of central precocious puberty, especially when puberty begins before age 8 in girls or 9 in boys. Genetic testing of the MKRN3 coding region can confirm the diagnosis.
MKRN3 is subject to genomic imprinting: only the copy inherited from the father is active. A pathogenic variant causes disease only when transmitted by the father; the same variant from the mother is silent because the maternal allele is normally silenced.
The mutation itself does not affect growth plates directly, but early activation of the hypothalamic‑pituitary‑gonadal axis can accelerate bone maturation, potentially reducing final adult height. Early treatment with GnRH analog therapy can pause puberty, allowing more time for growth.
First‑degree relatives, especially the father’s side, can be offered targeted testing for the known MKRN3 variant. If a parent carries the mutation, male offspring have a 50 % chance of inheriting the active allele and may develop precocious puberty; female offspring have the same risk. Early monitoring of growth and Tanner staging is recommended.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA